Fulop T - Search Results

1

Can an Infection Hypothesis Explain the Beta Amyloid Hypothesis of Alzheimer's Disease?

Fulop T, Witkowski JM, Bourgade K, Khalil A, Zerif E, Larbi A, Hirokawa K, Pawelec G, Bocti C, Lacombe G, Dupuis G, Frost EH. Fulop T, et al. Front Aging Neurosci. 2018 Jul 24;10:224. doi: 10.3389/fnagi.2018.00224. eCollection 2018. Front Aging Neurosci. 2018. PMID: 30087609 Free PMC article. Review.

2

Differential Phenotypes of Myeloid-Derived Suppressor and T Regulatory Cells and Cytokine Levels in Amnestic Mild Cognitive Impairment Subjects Compared to Mild Alzheimer Diseased Patients.

Le Page A, Garneau H, Dupuis G, Frost EH, Larbi A, Witkowski JM, Pawelec G, Fülöp T. Le Page A, et al. Among authors: fulop t. Front Immunol. 2017 Jul 7;8:783. doi: 10.3389/fimmu.2017.00783. eCollection 2017. Front Immunol. 2017. PMID: 28736551 Free PMC article.

3

Does HIV infection contribute to increased beta-amyloid synthesis and plaque formation leading to neurodegeneration and Alzheimer's disease?

Fulop T, Witkowski JM, Larbi A, Khalil A, Herbein G, Frost EH. Fulop T, et al. J Neurovirol. 2019 Oct;25(5):634-647. doi: 10.1007/s13365-019-00732-3. Epub 2019 Mar 13. J Neurovirol. 2019. PMID: 30868421 Review.

4

Beta-amyloid peptides enhance the proliferative response of activated CD4CD28 lymphocytes from Alzheimer disease patients and from healthy elderly.

Jóźwik A, Landowski J, Bidzan L, Fülop T, Bryl E, Witkowski JM. Jóźwik A, et al. Among authors: fulop t. PLoS One. 2012;7(3):e33276. doi: 10.1371/journal.pone.0033276. Epub 2012 Mar 12. PLoS One. 2012. PMID: 22428008 Free PMC article.

5

Elusive Alzheimer's disease: can immune signatures help our understanding of this challenging disease? Part 1: clinical and historical background.

Fulop T, Lacombe G, Cunnane S, Le Page A, Dupuis G, Frost EH, Bourgade-Navarro K, Goldeck D, Larbi A, Pawelec G. Fulop T, et al. Discov Med. 2013 Jan;15(80):23-32. Discov Med. 2013. PMID: 23375011 Free article. Review.

6

Elusive Alzheimer's disease: can immune signatures help our understanding of this challenging disease? Part 2: new immune paradigm.

Fulop T, Lacombe G, Cunnane S, Le Page A, Dupuis G, Frost EH, Bourgade-Navarro K, Goldeck D, Larbi A, Pawelec G. Fulop T, et al. Discov Med. 2013 Jan;15(80):33-42. Discov Med. 2013. PMID: 23375012 Free article. Review.

7

β-Amyloid peptides display protective activity against the human Alzheimer's disease-associated herpes simplex virus-1.

Bourgade K, Garneau H, Giroux G, Le Page AY, Bocti C, Dupuis G, Frost EH, Fülöp T Jr. Bourgade K, et al. Among authors: fulop t jr. Biogerontology. 2015 Feb;16(1):85-98. doi: 10.1007/s10522-014-9538-8. Epub 2014 Nov 7. Biogerontology. 2015. PMID: 25376108

8

NK Cells are Activated in Amnestic Mild Cognitive Impairment but not in Mild Alzheimer's Disease Patients.

Le Page A, Bourgade K, Lamoureux J, Frost E, Pawelec G, Larbi A, Witkowski JM, Dupuis G, Fülöp T. Le Page A, et al. Among authors: fulop t. J Alzheimers Dis. 2015;46(1):93-107. doi: 10.3233/JAD-143054. J Alzheimers Dis. 2015. PMID: 25720398

9

Protective Effect of Amyloid-β Peptides Against Herpes Simplex Virus-1 Infection in a Neuronal Cell Culture Model.

Bourgade K, Le Page A, Bocti C, Witkowski JM, Dupuis G, Frost EH, Fülöp T Jr. Bourgade K, et al. Among authors: fulop t jr. J Alzheimers Dis. 2016;50(4):1227-41. doi: 10.3233/JAD-150652. J Alzheimers Dis. 2016. PMID: 26836158

10

Peripheral Immune Signatures in Alzheimer Disease.

Goldeck D, Witkowski JM, Fülop T, Pawelec G. Goldeck D, et al. Among authors: fulop t. Curr Alzheimer Res. 2016;13(7):739-49. doi: 10.2174/1567205013666160222112444. Curr Alzheimer Res. 2016. PMID: 26899580 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

653 results

Search Page

Filters